Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?

Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?

Bibliographic Details
Main Authors:	Ana M. Rivas-Estilla, Sonia A. Lozano-Sepulveda
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268120300132

Similar Items

Antioxidants benefits in hepatitis C infection in the new DAAs era
by: Sonia A. Lozano-Sepúlveda, et al.
Published: (2019-05-01)

Treatment of hepatitis C virus genotype 4 in the DAA era
by: Antonio Di Biagio, et al.
Published: (2018-11-01)

Clinical application and management of DAA therapy for hepatitis C: an interpretation of 2015 AASLD guidelines for the management of hepatitis C
by: ZHANG Xiaxia, et al.
Published: (2015-11-01)

Effect of DAA therapy in hepatitis C treatment — an impulsive control approach
by: Amar Nath Chatterjee, et al.
Published: (2021-04-01)

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
by: Sylvia Drazilova, et al.
Published: (2018-01-01)

"Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
by: Neil Gupta, et al.
Published: (2017-01-01)

A Decade of Hepatitis C at the UCT/GSH Liver Clinic in the Pre-DAA era
by: Nordien, Rozeena
Published: (2020)

A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
by: Simone Monzani Vivaldini, et al.
Published: (2021-03-01)

O11 Hepatitis C: stigma indicators and patient reported outcome measures for DAA treatment
by: C. Treloar, et al.
Published: (2017-08-01)

P38 Hepatitis NSW's specialised counselling service: professional support for people undertaking DAA treatment for viral hepatitis C
by: L. Pesa, et al.
Published: (2017-08-01)

Treatment of hepatitis C using direct-acting antiviral (DAA) agents in patients undergoing liver transplantation
by: V. E. Syutkin, et al.
Published: (2016-02-01)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
by: A. Budkowska
Published: (2018-12-01)

Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
by: Haitham A. Azeem, et al.
Published: (2021-06-01)

Hepatitis C can be cured: will hepatitis B become next?
by: V P Chulanov, et al.
Published: (2017-11-01)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
by: Mirjam B. Zeisel, et al.
Published: (2015-11-01)

Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?
by: Mustafa Kemal ÇELEN, et al.
Published: (2018-06-01)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
by: D. E. Valutite, et al.
Published: (2018-12-01)

Hepatitis C virus – from Hippocrates to cure
by: Harvey J Alter
Published: (2016-01-01)

Viral hepatitis B and C. Cure or treatment?
by: Dimitrios A. Kountouras
Published: (2014-12-01)

Successes and Challenges on the Road to Cure Hepatitis C.
by: Stacy M Horner, et al.
Published: (2015-06-01)

Hepatitis C treatment: where are we now?
by: Burstow NJ, et al.
Published: (2017-02-01)

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs
by: Ghada El Sagheer, et al.
Published: (2018-01-01)

Implementation of hepatitis C cure in Australia: one year on
by: Jacqueline A. Richmond, et al.
Published: (2018-04-01)

The emergence of NASH issues after cure of hepatitis C
by: Lawrence Serfaty
Published: (2018-05-01)

Hepatitis C: milestones from discovery to clinical cure
by: Wei Hu, et al.
Published: (2020-12-01)

Experimental models for hepatitis C virus (HCV): New opportunities for combating hepatitis C
by: Karina del Carmen Trujillo-Murillo, Ph.D., et al.
Published: (2004-04-01)

Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?
by: Annie Madden, et al.
Published: (2018-01-01)

Prevention of Hepatitis C in Women
by: Beth P. Bell, et al.
Published: (2004-11-01)

Hepatitis C virus vaccine design: focus on the humoral immune response
by: Daniel Sepulveda-Crespo, et al.
Published: (2020-07-01)

“Sell an Ox” - The Price of Cure for Hepatitis C in Two Countries
by: Ora Paltiel, et al.
Published: (2020-06-01)

Risk of hepatocellular carcinoma after hepatitis C virus cure
by: Ali, M.J, et al.
Published: (2022)

On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era
by: Dana Busschots, et al.
Published: (2021-08-01)

Treatment of hepatitis C in HIV/HCV co-infected with direct-acting antiviral (DAA) regimens in a single clinic in Tripoli/Libya
by: N. Bousifi, et al.
Published: (2020-12-01)

Hepatitis type B is preventable and can be cured
by: Nikpoor
Published: (2001-01-01)

Treatment of hepatitis C in patients with thalassaemia. Where are we now?
by: Geoffrey Dusheiko
Published: (2013-03-01)

Hepatitis C From Infection to Cure
Published: (2018)

Where My Cord is Buried: WoDaaBe Use and Conceptualization of Land
by: Kristín Loftsdóttir
Published: (2001-12-01)

How I Combined Perseverance and Knowledge to Acquire My Cure for Hepatitis C and Beyond
by: Fred M Standeford BA
Published: (2016-03-01)

Successful Treatment of Hepatitis C Virus Infection Using Direct-Acting Antiviral Agents (DAAs) in Adolescents with Kidney Transplantation: A Case Series
by: Ambarsari CG, et al.
Published: (2020-06-01)

Focus on the treatment of chronic hepatitis C in children
by: NAN Yuemin
Published: (2018-02-01)

Cannot write session to /tmp/vufind_sessions/sess_bjg27h4cskml7ju3moakt6jq7a